×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| MANGALAM DRUGS & ORGANICS LTD. | 573.49 | -137.28 | 573.49 | -8.67 | 123.0 | 17.7 |
| Achyut Healthcare Limited | NA | NA | NA | NA | 123 | 223.0 |
| WELCURE DRUGS & PHARMACEUTICAL | NA | NA | NA | NA | 116 | 4.17 |
Mangalam Drugs and Organics Ltd., with Security Code 532637, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 91.1 | 87.5 | 81.6 | 97.3 | 102.2 | 76.5 | 79.9 | 88.7 | 73.0 | 57.3 |
| Expenses | 90.9 | 90.9 | 79.4 | 90.4 | 90.5 | 68.4 | 71.2 | 79.9 | 62.5 | 61.9 |
| Operating Profit | 0.2 | -3.5 | 2.2 | 7.0 | 11.7 | 8.2 | 8.7 | 8.8 | 10.6 | -4.5 |
| OPM % | 0.27% | -3.97% | 2.69% | 7.17% | 11.45% | 10.69% | 10.88% | 9.88% | 14.48% | -7.85% |
| Other Income | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | -0.1 | 0.0 |
| Interest | 3.4 | 3.4 | 3.2 | 3.3 | 4.0 | 3.7 | 3.7 | 3.5 | 4.0 | 4.0 |
| Depreciation | 2.8 | 3.4 | 3.7 | 3.6 | 3.9 | 3.9 | 4.0 | 3.9 | 4.6 | 4.4 |
| Profit before tax | -5.6 | -10.3 | -4.8 | 0.0 | 3.9 | 0.6 | 1.2 | 1.5 | 1.8 | -12.9 |
| Tax % | -22.4% | -7.3% | -25.1% | 1036.4% | -10% | 359% | 124.6% | 5.4% | -86.9% | -6.2% |
| Net Profit | -4.4 | -9.5 | -3.6 | 0.5 | 3.5 | 2.7 | 2.7 | 1.4 | 0.2 | -13.7 |
| EPS in Rs | -2.77 | -6.02 | -2.25 | 0.32 | 2.24 | 1.7 | 1.7 | 0.89 | 0.1 | -8.67 |
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 97.3 | 102.2 | 76.5 | 79.9 | 88.7 | 73.0 |
| Expenses | 0.0 | 90.4 | 90.5 | 68.3 | 71.2 | 79.9 | 62.9 |
| Operating Profit | 0.0 | 7.0 | 11.7 | 8.2 | 8.7 | 8.8 | 10.2 |
| OPM % | 0% | 7.17% | 11.44% | 10.7% | 10.89% | 9.89% | 13.93% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 |
| Interest | 0.0 | 3.3 | 4.0 | 3.7 | 3.7 | 3.5 | 4.0 |
| Depreciation | 0.0 | 3.6 | 3.9 | 3.9 | 4.0 | 4.1 | 4.7 |
| Profit before tax | 0.0 | 0.0 | 3.9 | 0.6 | 1.2 | 1.4 | 1.6 |
| Tax % | 0% | 1085.7% | -10.2% | -359% | -124.2% | -5.9% | -91.7% |
| Net Profit | 0.0 | 0.5 | 3.5 | 2.7 | 2.7 | 1.3 | 0.1 |
| EPS in Rs | 0.31 | 2.23 | 1.7 | 1.7 | 0.81 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 2% |
| 3 Years: | -11% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -4% |
| 3 Years: | -29% |
| TTM: | 177% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 4% |
| 3 Years: | -9% |
| 1 Year: | -28% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 175% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 4% |
| 3 Years: | -9% |
| 1 Year: | -28% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|